Drug Type Small molecule drug |
Synonyms TRC 041266, TRC041266 |
Target |
Mechanism AGER antagonists(Advanced glycosylation end product-specific receptor antagonists) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic heart failure | Phase 3 | - | 01 Jun 2021 | |
Diabetes Mellitus, Type 2 | Phase 3 | - | 01 Jun 2021 | |
Functional disorder | Phase 3 | - | 01 Jun 2021 |